Vaidya Sane Ayurved Laboratories Ltd Stock Price Today (NSE: MADHAVBAUG)
Vaidya Sane Ayurved Laboratories Ltd
Fundamental Score
Vaidya Sane Ayurved Laboratories Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Vaidya Sane Ayurved Laboratories Ltd share price today is ₹193.50, up +0.83% on NSE/BSE as of 31 July 2026. Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹215.42 (Cr). The 52-week high for MADHAVBAUG share price is ₹335.00 and the 52-week low is ₹164.20. At a P/E ratio of 23.96x, MADHAVBAUG is currently trading below its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 11.99% and a debt-to-equity ratio of 0.03.
Vaidya Sane Ayurved Laboratories Ltd Share Price Chart — NSE/BSE Historical Performance
Vaidya Sane Ayurved Laboratories Ltd share price chart: 3.48% return over the past month. 52-week high ₹335.00, 52-week low ₹164.20.
Vaidya Sane Ayurved Laboratories Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹191.90 | ₹194.00 | ₹182.35 | ₹193.50 | 4.40K (Cr) | |
| ₹191.90 | ₹191.90 | ₹191.90 | ₹191.90 | 800.00 (Cr) | |
| ₹191.90 | ₹191.90 | ₹191.90 | ₹191.90 | 400.00 (Cr) | |
| ₹191.90 | ₹191.90 | ₹191.90 | ₹191.90 | 800.00 (Cr) | |
| ₹200.10 | ₹202.00 | ₹200.00 | ₹202.00 | 1.20K (Cr) | |
| ₹206.05 | ₹209.00 | ₹201.00 | ₹206.35 | 4.80K (Cr) | |
| ₹208.00 | ₹208.80 | ₹208.00 | ₹208.80 | 800.00 (Cr) | |
| ₹203.00 | ₹207.00 | ₹202.25 | ₹207.00 | 1.20K (Cr) | |
| ₹223.95 | ₹223.95 | ₹200.00 | ₹204.90 | 3.60K (Cr) | |
| ₹186.85 | ₹186.90 | ₹178.00 | ₹182.00 | 5.60K (Cr) |
Vaidya Sane Ayurved Laboratories Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹187.00 | ₹223.95 | ₹178.00 | ₹193.50 | +3.48% | |
| ₹181.00 | ₹186.80 | ₹181.00 | ₹186.80 | +3.20% | |
| ₹259.90 | ₹280.00 | ₹183.40 | ₹187.00 | -28.05% | |
| ₹165.00 | ₹254.50 | ₹164.20 | ₹241.70 | +46.48% | |
| ₹200.25 | ₹201.00 | ₹175.00 | ₹175.00 | -12.61% | |
| ₹240.00 | ₹240.00 | ₹222.00 | ₹225.00 | -6.25% | |
| ₹282.75 | ₹282.75 | ₹222.00 | ₹226.50 | -19.89% | |
| ₹280.00 | ₹335.00 | ₹256.60 | ₹284.55 | +1.63% | |
| ₹270.40 | ₹283.00 | ₹262.80 | ₹271.10 | +0.26% | |
| ₹287.00 | ₹287.00 | ₹257.00 | ₹272.00 | -5.23% | |
| ₹287.95 | ₹313.00 | ₹270.25 | ₹289.90 | +0.68% | |
| ₹244.85 | ₹294.40 | ₹232.00 | ₹282.95 | +15.56% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Vaidya Sane Ayurved Laboratories Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Vaidya Sane Ayurved Laboratories Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MADHAVBAUG across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Excellent ROCE Performance (15.14%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 23.96 vs Industry: 36.70)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (18.37%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (13.72x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (66.34%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Vaidya Sane Ayurved Laboratories Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Vaidya Sane Ayurved Laboratories Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
32.1/100 | ₹193.50₹194 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
38.2/100 | ₹147.10₹147 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Fischer Medical Ventures Ltd share price2522.43 Cr
- Tarsons Products Ltd share price1588.16 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
Vaidya Sane Ayurved Laboratories Ltd Quarterly Performance
Latest quarterly metrics for MADHAVBAUG — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
18.37%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-0.24%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Vaidya Sane Ayurved Laboratories Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MADHAVBAUG — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Vaidya Sane Ayurved Laboratories Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Vaidya Sane Ayurved Laboratories Ltd
About MADHAVBAUG (Vaidya Sane Ayurved Laboratories Ltd)
Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equip...ment & Supplies sector with a current market capitalisation of ₹215.42 (Cr). Vaidya Sane Ayurved Laboratories Ltd has delivered a Return on Equity (ROE) of 11.99% and a ROCE of 15.14%. The debt-to-equity ratio stands at 0.03, reflecting the company's capital structure. Investors tracking MADHAVBAUG share price can monitor key metrics including P/E ratio, promoter holding of 66.34%, and quarterly earnings growth.
Company Details
MADHAVBAUG Share Price: Frequently Asked Questions
What is the current share price of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) trades at ₹193.50 on NSE. Market cap ₹215.42 (Cr). Educational data only.
What is the P/E ratio of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd has a P/E of 23.96x vs industry average 36.70x.
What is the Bull Run score for Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd has a Bull Run score of 32.1/100 based on 25+ financial parameters.
Does Vaidya Sane Ayurved Laboratories Ltd pay dividends?
Vaidya Sane Ayurved Laboratories Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd has ROE of 11.99%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd has debt-to-equity of 0.03.
Is Vaidya Sane Ayurved Laboratories Ltd a good investment?
Bull Run gives Vaidya Sane Ayurved Laboratories Ltd a score of 32.1/100. This is not investment advice — consult a SEBI-registered advisor.